Huluwa Pharmaceutical Group Wins the 2025 Outstanding Brand Award

From May 13 to 15, the 92nd PHARMCHINA grandly opened in Shanghai, attracting more than 2,000 pharmaceutical companies and over 100,000 industry professionals from across the country to gather and participate in this major industry event. During the exhibition, the 6th Houpo Yuanzhi Pharmaceutical Investment Forum and the 7th Traditional Chinese Medicine Marketing Innovation and Development Forum were held concurrently. The forums focused on core industry topics such as business model transformation, marketing innovation, and breakthroughs in retail development, bringing together industry experts, entrepreneurs, and distributors nationwide to jointly explore new pathways for industry development.

Huluwa Pharmaceutical Group was invited to participate in the event. Its key product, Xiao'er Feire Kechuan Granules (4g), secured the 2025 Outstanding Brand Award in one stroke, thanks to its outstanding product quality and strong market reputation, fully demonstrating the company's deep brand heritage and high-level industry recognition.

As a leading enterprise in China's pediatric pharmaceutical sector, Huluwa Pharmaceutical Group's participation in the National Pharmaceutical Trade Fair and its receipt of this major award represent high recognition from the market, the industry, and consumers of the company's overall strength, product quality, and brand influence.

Looking ahead, Huluwa Pharmaceutical Group will remain true to its founding mission in pharmaceutical manufacturing. With technological innovation as its core competitiveness, the company will actively embrace industry transformation, continue to deepen the integration of AI technology with the pharmaceutical industry, and optimize its product portfolio and service system. Upholding the philosophy of inheriting and innovating traditional Chinese medicine, the Group will work with industry partners to explore new market opportunities, lead the development of the pediatric pharmaceutical sector through its brand strength, and contribute to the high-quality advancement of the traditional Chinese medicine industry.